RDC 653: Changes to the transportation and storage of medicines
RDC 653 introduces important corrections to the management of temperature control of goods and the period of application of the rules.
Anvisa warns about aesthetic products used in injectable form
Anvisa warns that aesthetic products intended for injectable procedures cannot be regulated as cosmetics.
Cofepris authorizes new influenza vaccine for seniors
Cofepris, Mexico’s regulatory agency, authorizes new influenza vaccine for seniors, plus 165 new health supplies.
Sindusfarma calls for new regulatory framework for drug labeling
The central issue raised by sindusfarma is the difficulty of inserting the aforementioned phrases into primary packaging.
Infarmed authorized innovative medicine for several types of cancer
Pembrolizumab can be used, among others in the treatment of metastatic triple negative breast cancer.
Warnings to prevent antibiotic breakouts this winter
At stake are medicines intended for the treatment of respiratory infections.
Cofepris detects 7 new irregular drug distributors in the country
Cofepris performs strict surveillance to verify that companies do not violate the regulation.
Our team were present at FISA in São Paulo!
The largest innovation meeting for the ingredients, food and beverage sector in South America.
New rules for drug labeling in Brazil
The new codes only address the type of application without specifying the regulatory category of the medicine.
Malaysians to intensify bilateral trade in health products with Brazil
This opportunity opens doors for Brazilian companies to export to Southeast Asia.